US5194590A
(en)
*
|
1986-06-20 |
1993-03-16 |
Northfield Laboratories, Inc. |
Acellular red blood cell substitute
|
US5464814A
(en)
*
|
1986-06-20 |
1995-11-07 |
Northfield Laboratories, Inc. |
Acellular red blood cell substitute
|
US5084558A
(en)
*
|
1987-10-13 |
1992-01-28 |
Biopure Corporation |
Extra pure semi-synthetic blood substitute
|
US5854209A
(en)
*
|
1995-03-23 |
1998-12-29 |
Biopure Corporation |
Method for oxygenating tissue having reduced red blood cell flow
|
US5955581A
(en)
*
|
1986-11-10 |
1999-09-21 |
Biopure Corporation |
Method for producing a stable polymerized hemoglobin blood-substitute
|
CA1312009C
(en)
*
|
1986-11-10 |
1992-12-29 |
Carl W. Rausch |
Extra pure semi-synthetic blood substitute
|
US5753616A
(en)
*
|
1986-11-10 |
1998-05-19 |
Biopure Corporation |
Method for producing a stable polymerized hemoglobin blood-substitute
|
GB8711614D0
(en)
*
|
1987-05-16 |
1987-06-24 |
Medical Res Council |
Proteins
|
US5449759A
(en)
*
|
1987-05-16 |
1995-09-12 |
Somatogen, Inc. |
Hemoglobins with intersubunit desulfide bonds
|
US6022849A
(en)
*
|
1987-05-16 |
2000-02-08 |
Baxter Biotech Technology Saarl |
Mutant recombinant hemoglobins containing heme pocket mutations
|
DE3888199T2
(de)
*
|
1987-12-03 |
1994-06-09 |
Chloride Silent Power Ltd |
Alkalimetallzelle.
|
US6204009B1
(en)
|
1988-05-16 |
2001-03-20 |
BAXTER BIOTECH TECHNOLOGY SàRL |
Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations
|
IL87707A
(en)
*
|
1988-09-08 |
1994-06-24 |
Technion Inst For Research And |
Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof
|
IL87708A
(en)
*
|
1988-09-08 |
1994-04-12 |
Technion Inst For Research And |
Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof
|
US5545727A
(en)
*
|
1989-05-10 |
1996-08-13 |
Somatogen, Inc. |
DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
|
NL8901174A
(nl)
*
|
1989-05-10 |
1990-12-03 |
Het Hoofd Van De Afdeling Mili |
Hemoglobine-preparaat en gebruik daarvan.
|
US5439882A
(en)
*
|
1989-12-29 |
1995-08-08 |
Texas Tech University Health Sciences Center |
Blood substitute
|
AU9067791A
(en)
*
|
1990-11-20 |
1992-06-11 |
Enzon, Inc. |
Method of enhancing long-term storage stability of hemoglobin products
|
SK54993A3
(en)
*
|
1990-11-29 |
1993-10-06 |
Upjohn Co |
Imidoester cross-linked hemoglobin compositions
|
ATE168014T1
(de)
*
|
1991-11-08 |
1998-07-15 |
Somatogen Inc |
Hämoglobine als arzneimittelabgabesystem
|
US5334706A
(en)
*
|
1992-01-30 |
1994-08-02 |
Baxter International |
Administration of low dose hemoglobin to increase perfusion
|
US5900477A
(en)
*
|
1992-01-30 |
1999-05-04 |
Baxter International, Inc. |
Use of hemoglobin in the treatment of hemorrhagic shock
|
US5980954A
(en)
|
1992-02-07 |
1999-11-09 |
Vasogen Ireland Limited |
Treatment of autoimmune diseases
|
US5591457A
(en)
*
|
1992-02-07 |
1997-01-07 |
Vasogen Inc |
Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
|
US6669965B2
(en)
|
1992-02-07 |
2003-12-30 |
Vasogen Ireland Limited |
Method of treating atherosclerosis
|
GB9617611D0
(en)
*
|
1996-08-22 |
1996-10-02 |
Vasogen Inc |
Treatment of autoimmune disease
|
US5646252A
(en)
*
|
1992-02-10 |
1997-07-08 |
Staat Der Nederlanden, De Minister Van Defensie, Voor Deze: Het Hoofd Van De Afdeling Militair Geneeskundig Beleid |
Hemoglobin composition and preparation thereof
|
US6187744B1
(en)
|
1992-03-11 |
2001-02-13 |
Michael W. Rooney |
Methods and compositions for regulating the intravascular flow and oxygenating activity of hemoglobin in a human or animal subject
|
WO1995003068A1
(en)
*
|
1993-07-23 |
1995-02-02 |
The Upjohn Company |
Method for administering hemoglobin
|
IS4198A
(is)
*
|
1993-08-13 |
1995-02-14 |
Somatogen, Inc |
Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
|
TW381022B
(en)
*
|
1993-08-16 |
2000-02-01 |
Hsia Jen Chang |
Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
|
US5840701A
(en)
*
|
1993-08-16 |
1998-11-24 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5741893A
(en)
*
|
1993-08-16 |
1998-04-21 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5824781A
(en)
*
|
1993-08-16 |
1998-10-20 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5804561A
(en)
*
|
1993-08-16 |
1998-09-08 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5767089A
(en)
*
|
1993-08-16 |
1998-06-16 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5725839A
(en)
*
|
1993-08-16 |
1998-03-10 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
|
US5807831A
(en)
*
|
1993-08-16 |
1998-09-15 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5817632A
(en)
*
|
1993-08-16 |
1998-10-06 |
Hsia; Jen-Chang |
Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
|
US5631219A
(en)
*
|
1994-03-08 |
1997-05-20 |
Somatogen, Inc. |
Method of stimulating hematopoiesis with hemoglobin
|
US6242417B1
(en)
|
1994-03-08 |
2001-06-05 |
Somatogen, Inc. |
Stabilized compositions containing hemoglobin
|
US6458762B1
(en)
|
1994-03-28 |
2002-10-01 |
Baxter International, Inc. |
Therapeutic use of hemoglobin for preserving tissue viability and reducing restenosis
|
DE4418973A1
(de)
*
|
1994-05-31 |
1995-12-14 |
Barnikol Wolfgang |
Verfahren zur Herstellung molekular-einheitlicher hyperpolymerer Hämoglobine
|
US6271351B1
(en)
|
1995-03-23 |
2001-08-07 |
Biopure Corporation |
Method for preserving a hemoglobin blood substitute
|
US5895810A
(en)
*
|
1995-03-23 |
1999-04-20 |
Biopure Corporation |
Stable polymerized hemoglobin and use thereof
|
US6288027B1
(en)
|
1995-03-23 |
2001-09-11 |
Biopure Corporation |
Preserving a hemoglobin blood substitute with a transparent overwrap
|
US6610832B1
(en)
|
1995-03-23 |
2003-08-26 |
Biopure Corporation |
Preserving a hemoglobin blood substitute with a transparent overwrap
|
AU693354B2
(en)
*
|
1995-04-10 |
1998-06-25 |
Baxter International Inc. |
The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
|
US5952470A
(en)
*
|
1995-06-07 |
1999-09-14 |
Biopure Corporation |
Method for separating unmodified hemoglobin from cross-linked hemoglobin
|
US5741894A
(en)
*
|
1995-09-22 |
1998-04-21 |
Baxter International, Inc. |
Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
|
US5733869A
(en)
*
|
1995-10-06 |
1998-03-31 |
Baxter International, Inc. |
Therapeutic administration of hemoglobin in cardiac arrest
|
CA2236794A1
(en)
*
|
1995-11-30 |
1997-06-05 |
Bruce A. Kerwin |
Method for control of functionality during cross-linking of hemoglobins
|
AU715914B2
(en)
|
1995-12-22 |
2000-02-10 |
Baxter Biotech Technology S.A.R.L. |
Globins containing binding domains
|
ATE241646T1
(de)
*
|
1996-03-28 |
2003-06-15 |
Northfield Lab |
Verfahren und vorrichtung zur herstellung eines zellfreien ersatzes roter blutzellen
|
US5814601A
(en)
*
|
1997-02-28 |
1998-09-29 |
The Regents Of The University Of California |
Methods and compositions for optimization of oxygen transport by cell-free systems
|
EP1011710B1
(de)
*
|
1997-02-28 |
2005-08-17 |
The Regents of the University of California |
Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
|
EP0885613A1
(de)
*
|
1997-06-21 |
1998-12-23 |
Roche Diagnostics GmbH |
Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
|
DE19802321C2
(de)
*
|
1998-01-23 |
2000-05-11 |
Fresenius Ag |
Verfahren und Vorrichtung zur Aufbereitung von intra- oder postoperativen Blutverlusten für die Autotransfusion
|
WO2001034648A1
(en)
|
1999-11-12 |
2001-05-17 |
Baxter International, Inc. |
Reduced side-effect hemoglobin compositions
|
US6747132B2
(en)
|
2000-11-29 |
2004-06-08 |
Apex Biosciences, Inc. |
Methods for the synthesis of a modified hemoglobin solution
|
US6518010B2
(en)
|
2001-02-28 |
2003-02-11 |
Biopure Corporation |
Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier
|
AU2002254646B2
(en)
|
2001-04-18 |
2008-05-15 |
Northfield Laboratories, Inc. |
Flexible container system for storage of stabilized hemoglobin solutions
|
US20030153491A1
(en)
*
|
2002-01-11 |
2003-08-14 |
Winslow Robert M. |
Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
|
EP1894573A3
(de)
|
2002-01-11 |
2013-06-12 |
Sangart, Inc. |
Verfahren und Zusammensetzungen für den Sauerstofftransport mit hoher Sauerstoffaffinität
|
EP1469811A4
(de)
*
|
2002-01-11 |
2006-01-04 |
Sangart Inc |
Verfahren und zusammensetzungen für den sauerstofftransport mit modifiziertem hämoglobin in plasma
|
AU2003202941A1
(en)
*
|
2002-01-11 |
2003-07-30 |
Sangart, Inc. |
Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution
|
US20050164915A1
(en)
*
|
2002-04-01 |
2005-07-28 |
Sangart, Inc. |
Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
|
US7001715B2
(en)
*
|
2002-02-28 |
2006-02-21 |
Biopure Corporation |
Purification of red blood cells by separation and diafiltration
|
JP3912206B2
(ja)
*
|
2002-07-05 |
2007-05-09 |
株式会社日立製作所 |
筒内直接燃料噴射装置用燃料ポンプ
|
CA2499459A1
(en)
*
|
2002-10-03 |
2004-05-06 |
Northfield Laboratories, Inc. |
Polymerized hemoglobin solution for treating patients with massive blood loss
|
US7501114B2
(en)
*
|
2002-12-02 |
2009-03-10 |
Biovec, Llc |
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
|
CA2508514A1
(en)
*
|
2002-12-02 |
2004-06-17 |
Biovec Llc |
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
|
US7803365B2
(en)
*
|
2002-12-02 |
2010-09-28 |
Biovec, Llc |
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
|
US9388427B2
(en)
|
2002-12-02 |
2016-07-12 |
Biovec, Llc |
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
|
US7481998B2
(en)
*
|
2002-12-02 |
2009-01-27 |
Biovec, Llc |
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
|
AU2004207595B2
(en)
*
|
2003-01-29 |
2009-02-05 |
Northfield Laboratories, Inc. |
Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
|
US7135554B1
(en)
*
|
2004-01-27 |
2006-11-14 |
Biopure Corporation |
Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
|
CA2578232C
(en)
*
|
2004-08-31 |
2015-12-29 |
Sangart, Inc. |
Methods to enhance hemodynamic stability using oxygen carrying compositions
|
WO2006108047A2
(en)
*
|
2005-04-05 |
2006-10-12 |
Biopure Corporation |
Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization
|
US20090004159A1
(en)
*
|
2006-01-24 |
2009-01-01 |
The Board Of Trustees Of The University Of Illinoi |
Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
|
WO2007087570A2
(en)
*
|
2006-01-24 |
2007-08-02 |
Northfield Laboratories, Inc. |
Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
|
US7759306B2
(en)
*
|
2006-05-16 |
2010-07-20 |
Simoni Jan S |
Methods of treating acute blood loss
|
US20080118572A1
(en)
*
|
2006-10-10 |
2008-05-22 |
Harold Richard Hellstrom |
Methods and compositions for reducing the risk of adverse cardiovascular events associated with the administration of artificial blood
|
US8273857B2
(en)
*
|
2009-09-22 |
2012-09-25 |
Jen-Chang Hsia |
Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
|
ES2699579T3
(es)
|
2013-05-03 |
2019-02-11 |
Univ Washington |
Composición sustituta de la sangre y procedimiento de uso
|
WO2020080978A2
(ru)
*
|
2018-10-19 |
2020-04-23 |
Рахимджан Ахметджанович РОЗИЕВ |
Cпособ получения кровезаменителя для применения в ветеринарии
|
CN114146165B
(zh)
*
|
2021-12-02 |
2022-08-12 |
润方(北京)生物医药研究院有限公司 |
一种聚合血红蛋白在制备防治呼吸衰竭药物中的应用
|